DVA vs IRD · P/E 14, rev $12.82B vs rev $11.0M
DaVita HealthCare Partners Inc (DVA) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. IRD currently screens at market cap $35.7M.
Not investment advice. Open the DVA and IRD stock pages for the full models.
Not investment advice.